Why is Prenetics stock rallying today?

Prenetics stock experienced a 3.3% increase in pre-market trading following the release of its Q2 FY2026 financial results, which exceeded expectations and reflected a strong performance in the company's IM8 wellness brand. The IM8 brand generated $45.0 million in revenue for the quarter, marking a remarkable 359% year-over-year increase, signaling a streak of six consecutive record quarters.

This impressive growth was further bolstered by the positive turning point in Adjusted Free Cash Flow, a milestone CEO Danny Yeung highlighted as the most significant achievement since the brand's inception. The company also raised its full-year 2026 revenue guidance to $220–$230 million and announced ambitious FY2027 IM8 revenue guidance of $400 million or more, with the latter projection assuming no impact from upcoming product launches.

This pre-market rally stands out even more given the broader market sentiment, with the Nasdaq Composite down 1.3% and the S&P 500 off 0.5%, indicative of caution due to geopolitical tensions and rising oil prices. Investors were clearly drawn to Prenetics' clean earnings beat, surpassing its guidance range, the record-breaking July performance, the first-ever positive free cash flow, and the aggressive forward guidance raise, driving the stock price towards $20.01 and near its 52-week high of $23.63.